Ignite Creation Date:
2025-12-24 @ 7:44 PM
Ignite Modification Date:
2026-02-25 @ 8:49 PM
Study NCT ID:
NCT03654703
Status:
UNKNOWN
Last Update Posted:
2018-08-31
First Post:
2018-08-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML
Sponsor:
Capital Research Institute of Pediatrics
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
CIP-2015-AML
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None